Next Article in Journal
Massive Axial and Appendicular Skeletal Deformities in Connection with Gorham-Stout Syndrome
Next Article in Special Issue
In Vitro Effect of the Traditional Medicine Hainosan (Painongsan) on Porphyromonas gingivalis
Previous Article in Journal
Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”
Previous Article in Special Issue
A New Approach for Indexing Honey for Its Heath/Medicinal Benefits: Visualization of the Concept by Indexing Based on Antioxidant and Antibacterial Activities
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical Composition and Biological Activities of Wild Scolymus maculatus L.

1
Faculty of Pharmacy, Al-Quds University, Abu-Dies 144, Palestine
2
QRC—Qasemi Research Center, Al-Qasemi Academic College, Baka El-Ghrabiah 30100, Israel
3
Central Public Health Laboratory, Ministry of Health, Ramallah 4284, Palestine
4
Faculty of Medicine, Al-Quds University, Abu-Dies 144, Palestine
5
Drug Discovery Informatics Lab, the Institute of Applied Research - Galilee Society, Shefa-Amr 20200, Israel
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Medicines 2019, 6(2), 53; https://doi.org/10.3390/medicines6020053
Submission received: 21 March 2019 / Revised: 19 April 2019 / Accepted: 27 April 2019 / Published: 30 April 2019
(This article belongs to the Special Issue Natural Compounds as Potential Antibacterial Agents)

Abstract

:
Background: The wild population of spotted golden thistle, Scolymus maculatus, which belongs to the Compositae family, is believed to be one of the multi-curative wild plants mentioned in Flora Palaestina. This study aims to disclose the phytochemical composition, antioxidant potential, and antimicrobial activity of wild S. maculatus collected from the farms of Kabul, a village in northwest Galilee, for the first time. Methods: The phytochemical components of crude S. maculatus extracts from methanol, ethyl acetate, and n-hexane solvents were separated and identified using gas chromatography-mass spectrometry (GC-MS) in the electron impact (EI) mode. The free radical scavenging of the plant extracts was measured by DPPH assay. The microdilution test was used to determine the minimum inhibitory concentrations (MICs) of different S. maculatus extracts and to evaluate their antimicrobial activities. Results: Thirty-two phytochemicals were found in S. maculatus extracts including stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and β-amyrin. Phytochemicals, such as 2-linoleoylglycerol, γ-sitosterol, β-amyrin, lupeol, (3α)-12-oleanen-3-yl acetate, and lupenyl acetate, were found to dominate the methanol extract. Most of these compounds were also observed in ethyl acetate and n-hexane extracts, but at different levels, in addition to some other minor compounds. The various extracts were investigated for their antioxidant and antimicrobial activity. The ethanolic and the methanolic extracts were shown to exhibit the highest free radical scavenging by DPPH assay with a half-maximally effective concentration (EC50) of 0.37 and 0.65 mg/mL respectively, while the other three extracts (aqueous, ethyl acetate and n-hexane) were less active and their EC50 (effective concentration at which DPPH radical was scavenged by 50%) were above 1.0 mg/mL. Moreover, MICs were determined to be effective against Staphylococcus aureus, Salmonella typhimurium, and Candida albicans microorganisms. Ethyl acetate and the ethanolic extracts are active against the three types of microorganisms at a minimum inhibitory concentration (MIC) of 0.5 mg/mL, while aqueous and the n-hexane extracts are inactive against Salmonella typhimurium. Conclusions: The results show that S. maculatus extracts are a rich source of compounds that can play an important role in human health, and in a broader context, in the treatment of various diseases, such antimicrobial and antioxidant-related ailments.

Graphical Abstract

1. Introduction

Plant-based nutrients and natural products have long been considered to be linked with human health and even evidenced to reduce risks of chronic human illnesses, such as inflammation [1,2,3], diabetes [4], cancer [5,6], and microbial-related diseases [7,8,9,10,11]. To date, herbal medicine is widely practiced in Palestine [12]. Well-reputed, it plays an integral part in the cultural heritage and public healthcare practices of the region. A paucity of herbal products used in folk medicine has been scientifically investigated and recorded [13,14]. The efficacy, safety, toxicity, dosage, and the usage instructions for medicinal plants are generally transmitted verbally from one generation to another [14]. One of the putative multi-curative wild herbal plants of Flora Palaestina is the spotted golden thistle, S. maculatus (Compositae family). This wild plant is very common in the Mediterranean region [15]. Its shape is very similar to the famous milk thistle plant, Silybum marianum (L.), which is used to protect the liver. S. marianum’s main active ingredients are silybin, silydianin, and silychristine, collectively known as silymarin [15]. S. maculatus, however, is also believed to contain other useful phytochemicals that may prevent and treat diseases, such as liver disease, cancer, and diabetes. Moreover, a stem decoction is traditionally prepared to treat intestinal and kidney inflammation [15]. In light of this, wild S. maculatus phytochemicals from methanol, ethyl acetate, and n-hexane solvents were investigated using gas chromatography-mass spectrometry (GC-MS) in the electron impact (EI) mode to identify authentic principal compounds. Thirty-two phytochemicals were detected for the first time in S. maculatus. Moreover, in vitro antioxidant activities were tested using DPPH assay. MICs were determined for effectiveness against Staphylococcus aureus (S. aureus), Salmonella typhimurium, and Candida albicans microorganisms.

2. Materials and Methods

2.1. Plant Collection and Extract Preparation

Whole S. maculatus plants, comprising stems and flowers, were collected from the farms of the village of Kabul in the northwest of Galilee during October 2014. The plant was identified and authenticated by Dr. Khaled Sawalha, a botanist from the Biology Department of Al-Quds University. The specimens were washed with distilled water and dried in the shade for three weeks. Two hundred milliliters each of water, methanol, ethanol, ethyl acetate, and n-hexane were added separately to the dried ground plant material (20 g) in a beaker, and all the samples were sonicated for 60 min at 45 °C, then left in a dark glass bottle for 24 h for complete extraction. The extracts were filtered by passing the solvents through a 0.2 µm filter. Ten milliliters were taken from the extracts for GC-MS tests. The solvent remaining from each extract was evaporated with a rotary vacuum evaporator under reduced pressure. The yields of the extracts (w/w%) were 3.3%, 3.7%, 2.4%, 7.9%, and 2.3% for aqueous, methanolic, ethanolic, ethyl acetate, and n-hexane, respectively. The crude extracts were dissolved in DMSO to prepare stock solutions with a 16.0 mg/mL concentration, then subjected to free radical scavenging tests using DPPH assay. Microdilution tests were conducted to determine MICs of the extracts against Staphylococcus aureus, Salmonella typhimurium, and Candida albicans microorganisms. The chemical compositions of the three extracts were verified by GC-MS.

2.2. Instrumentation

The extracts were analyzed using a Perkin Elmer, Clarus gas chromatograph connected to a Clarus 600 C mass spectrometer (GC-MSPerkinElmer, Inc, Shelton, CT, USA). The GC-MS was operated in the electron impact ionization mode (EI) at 70 eV. A Perkin Elmer autosampler was used with 2 mL vials. The capillary GC column (DB-5 MS, Agilent Technologies, Inc, Santa Clara, CA, USA) was equipped with fused silica that consisted of 5% diphenyl polysiloxane and 95% dimethyl polysiloxane, 28 m × 0.25 mm, with a coating film thickness of 0.25 µm (Restek Corporation, Bellefonte, PA, USA).

2.3. GC-MS Chromatographic Condition

The flow rate of the carrier gas was 1 mL He/min. The injector temperature was set at 235 °C, the source temperature at 250 °C, and the interface temperature at 260 °C. A split ratio of 1:20 was adopted during the entire analysis. The column gradient temperature was held at 50 °C for two minutes, then raised from 50 °C to 180 °C at a ramp rate of 5 °C/min and from 180 °C to 280 °C at a ramp rate of 15 °C/min and held there for an extra five minutes. A solvent cut time of 4.5 min was used to eliminate the solvent’s gigantic peak. The mass range was from 50 up to 480 Da, with a scan interval of 0.2 seconds. The identification of compounds was mainly based on matching their MS spectra with those of NIST mass spectral library.

2.4. Free Radical Scavenging Capabilities of Extracts

The free radical scavenging of different concentrations of the S. maculatus plant extracts was measured by DPPH assay [16]. One-milliliter portions of the plant extract were added to one-milliliter ethanolic DPPH solution (with a concentration of 100 ppm). The assay was performed using two-fold serial dilution by DMSO, starting from the stock solution of the plant extract. The mixture was shaken strongly and allowed to stand for 30 min at room temperature in a dark place. The absorbance of the solution was measured at 517 nm and converted into a percentage of free radical scavenging (FRS%) using the following equation:
FRS% = 100 × {1 − [(Asample − Ablank))/(Acontrol − Ablank)]}
where, Asample is the absorbance of the mixture (plant extract and DPPH), Ablank is the absorbance of the plant extract solution, and Acontrol is the absorbance of the ethanolic solution of DPPH.
Free radical scavenging at each concentration was repeated four times, and the data were expressed as the average ± the standard error of the means of the four experiments. Gallic acid was used as a positive control. The scavenging potential of the gallic acid and the various extracts was evaluated by the DPPH assay test and was expressed in terms of half-maximal effective concentration (EC50), where EC50 is defined as the concentration that causes a decrease in the initial DPPH concentration by 50%. The EC50 value was determined by extracting the equation for the linear part of the graph and substituting 50% for the y value, while calculating the concentration value of the x-axis.

2.5. Antibacterial and Antifungal Activity

Microdilution tests were used to determine the MICs of the different samples. The broth microdilution assay was performed using twofold serial dilution in brain heart infusion (BHI) broth. The test was carried out in 96-well flat-bottomed microtitration plates. The cell suspension was prepared in BHI broth with an optical density equivalent to 0.5 of the McFarland standards, and diluted 1:100 in BHI broth to obtain a final concentration of 5 × 105 colony-forming units per milliliter (CFU/mL). Controls with broth only and broth with bacteria without any of the antibacterial agents were also included in each plat. One hundred µl of the antibacterial agent were put in the first microplate well and serially diluted in BHI broth. One hundred µl, corresponding to 5 × 105 CFU/mL, were added to all the wells. The plates were incubated at 37 °C for 18 h overnight. Erythromycin was used as a positive control for S. aureus, while nystatin was used as a positive control for Candida albicans and Tetracycline for Salmonella typhimurium strain LT2. The minimum inhibitory concentration (MIC) was defined as the lowest concentration able to inhibit the visible growth of bacteria in triplicate wells. After the MIC was visually determined, twenty microliters of p-iodonitrotetrazolium violet (8 mg/mL EtOH) were added to each well. The plate was incubated for another 30 min and assessed visually for any change in color from yellow to pink, which would indicate the reduction of dye due to bacterial growth.

2.6. Statistical Analysis

Statistical analyses were performed using Excel spreadsheet software (v16.0, Microsoft, Redmond, WA, USA). All experiments were conducted in quadruplicate, and the data were expressed as an average ± standard deviation. A p-value (calculated by t-test) of less than 0.05 was considered statistically significant.

3. Results and Discussion

In this study, the phytochemical composition of wild S. maculatus methanol, ethyl acetate and n-hexane crude extracts was revealed. GC-MS screening in the electron impact mode (EI) revealed about 32 compounds for the first time. A satisfactory resolution and elution time were obtained on the capillary GC DB-5 column used (Figure 1). Of the 32 compounds seen in Table 1 and Figure 2, stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and α-amyrin are known to exhibit important pharmacological activity, in particular anticancer, anti-inflammatory, and antibacterial activity [17,18,19]. Phytochemicals, such as 2-linoleoylglycerol (5.87%), γ-sitosterol (5.73%), β-amyrin (15.98%), lupeol (22.25%), (3α)-12-oleanen-3-yl acetate (9.14%), and lupenyl acetate (18.11%,) dominated the methanol extract (see Table 1 and Figure 1 and Figure 2). Almost all of these compounds were observed in ethyl acetate and n-hexane extracts, but in different proportions.
It is worth noting that sitosterol has been reported to possess antibacterial potential [20]. Stigmasterol exhibits antibacterial activity against methicillin-resistant Staphylococcus aureus [16] and has been reported as well to significantly inhibit tumor promotion in two-stage carcinogenesis in mice [21]. A mixture of sitosterol and stigmasterol has been shown to possess anti-inflammatory activity after topical application [22]. Therefore, it is expected that the presence of such sterols in S. maculatus would be of paramount importance for combating and curing diseases.
Lupeol (Figure 2), another significant phytochemical in S. maculatus, is about 22% in the identified peaks in the methanol extract. Numerous preclinical animal studies suggest that lupeol has potential as anti-inflammatory, anti-microbial, anti-protozoal, anti-proliferative, anti-invasive, anti-angiogenic and cholesterol-lowering agent [23]. β-amyrin (Table 1 and Figure 2), which was found in the methanol and n-hexane extract in about 16% and 5.44%, respectively, were reported recently to have significant anticancer activity [24], and a recent study highlights the potential of both lupeol and stigmasterol as new, promising anti-MRSA (methicillin-resistant Staphylococcus aureus) agents [16]. β-amyrin from L. microcladia natural product has shown potential antibacterial activity [25]. The authors suggest intensifying the study on L. microcladia as a source of β-amyrin. Moreover, among the three molecules that were isolated from S. globulifera, lupeol and β-amyrin exhibit potential as new anti-Enterococcus compounds [26]. Growth inhibition of Streptococcus from the oral cavity by α-and β-amyrin terpenoids and α-amyrin esters have also been reported [27]. Table 1 shows the presence of α,β-unsaturated aliphatic aldehydes, such as 2,4-decadienal. Recent studies also demonstrate the capability of such a compound to combat bacterial growth [28,29].
The antioxidant reacts with the stable free radical DPPH and converts it to 1, 1-diphenyl-2-picryl hydrazine. The ability to scavenge the free radical DPPH was measured at an absorbing wavelength of 517 nm. All the extracts of S. maculatus were tested for their free radical scavenging activity. The EC50 values of the five extracts are shown in Table 2 and Figure 3. The ethanolic extract is the most active (probably containing a higher concentration of antioxidants) while the n-hexane extract is the least active one.
Antibacterial activity was anticipated because of the presence of compounds, such as lupeol, amyrin, sitosterol, and stigmasterol, which have shown potential antibacterial potential [20,25,30]. Therefore, the aqueous, methanol, ethanol, ethyl acetate, and n-hexane extracts of wild S. maculatus were evaluated in comparison to tetracycline, erythromycin and nystatin positive controls. The aqueous extract was deliberately used to imitate the usual method of plant decoction. The MICs against Staphylococcus aureus, Salmonella typhimurium, and Candida albicans microorganisms were determined. The ethyl acetate and the ethanolic extracts were active against the three types of microorganisms, with a MIC of 0.5 mg/mL, while the aqueous and the n-hexane extracts were inactive against Salmonella typhimurium (Table 3). The methanolic extract was active against Staphylococcus aureus and Candida albicans but not against Salmonella typhimurium.

4. Conclusions

Thirty-two volatile components were detected in wild S. maculatus for the first time. Lupeol was the predominant component, with a percentage exceeding 22% in methanol. Lupeol acetate was the principle phytochemical in the ethyl acetate extract (26%) and to a lesser extent (11%) in n-hexane. Stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and β-amyrin, which are reported here for the first time as phytochemical components in S. maculatus, are biologically active compounds according to scientific literature and most likely responsible for some of the activities of wild S. maculatus. Isolation of all antioxidant and antimicrobial chemicals from the most active extracts and testing their contribution to the biological activities of wild S. maculatus and potential synergism is recommended. The findings disclosed herein are important and may suggest the importance of consuming S. maculatus as food. Enriched extracts could be prepared that possess certain activity beneficial to human health, and in a broader context, that could be useful for the treatment of various diseases. As well, S. maculatus could be a source of promising lead compounds for the development of new treatments for microbial-related diseases and some other diseases.

Author Contributions

All seven authors contributed extensively to the work presented in this paper. Conceptualization, A.R. and S.A.-L.; methodology, M.R., B.A.-F., and M.M.; validation, H.A.-J., M.M., and B.A.-F.; formal analysis, M.A.-L.; investigation, M.M. and H.A.-J.; resources, S.A.-L. and A.R.; writing-original draft preparation, S.A.-L., M.R., and M.A.-L; writing-review & editing, A.R.; project administration, A.R.; funding acquisition, A.R. and S.A.-L.

Funding

Al-Qasemi Research and Development Authority as well as the Ministry of Science, Technology and Space.

Acknowledgments

We would like to thank the Central Public Health Laboratory in Ramallah for facilitating the use of the GC-MS instrument.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

DPPHdiphenylpicrylhydrazyl
AAantioxidant activity
MICminimum inhibitory concentration
GC-MSgas chromatography-mass spectrometry
EIelectron impact
BHIbrain heart infusion
EC50half-maximal effective concentration
TICtotal ion chromatogram

References

  1. Aswad, M.; Rayan, M.; Abu-Lafi, S.; Falah, M.; Raiyn, J.; Abdallah, Z. Nature is the best source of anti-inflammatory drugs: Indexing natural products for their anti-inflammatory bioactivity. Inflamm. Res. 2018, 67, 67–75. [Google Scholar] [CrossRef] [PubMed]
  2. Frank, A.; Abu-Lafi, S.; Adawi, A.; Schwed, J.S.; Stark, H.; Rayan, A. From medicinal plant extracts to defined chemical compounds targeting the histamine H4 receptor: Curcuma longa in the treatment of inflammation. Inflamm. Res. 2017, 66, 923–929. [Google Scholar] [CrossRef]
  3. Zaid, H.; Raiyn, J.; Osman, M.; Falah, M.; Srouji, S.; Rayan, A. In silico modeling techniques for predicting the tertiary structure of human H4 receptor. Front. Biosci. 2016, 21, 597–619. [Google Scholar]
  4. Zeidan, M.; Rayan, M.; Zeidan, N.; Falah, M.; Rayan, A. Indexing natural products for their potential anti-diabetic activity: Filtering and mapping discriminative physicochemical properties. Molecules 2017, 22, 1563. [Google Scholar] [CrossRef]
  5. Chikara, S.; Nagaprashantha, L.D.; Singhal, J.; Horne, D.; Awasthi, S.; Singhal, S.S. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Cancer Lett. 2018, 413, 122–134. [Google Scholar] [CrossRef] [PubMed]
  6. Rayan, A.; Raiyn, J.; Falah, M. Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. PLoS ONE 2017, 12, e0187925. [Google Scholar] [CrossRef]
  7. Kacergius, T.; Abu-Lafi, S.; Kirkliauskiene, A.; Kirkliauskiene, A.; Gabe, V.; Adawi, A.; Rayan, M.; Qutob, M.; Stukas, R.; Utkus, A.; et al. Inhibitory capacity of Rhus coriaria L. extract and its major component methyl gallate on Streptococcus mutans biofilm formation by optical profilometry: Potential applications for oral health. Mol. Med. Rep. 2017, 16, 949–956. [Google Scholar] [CrossRef] [PubMed]
  8. Gabe, V.; Kacergius, T.; Abu-Lafi, S.; Kalesinskas, P.; Masalha, M.; Falah, M.; Abu-Farich, B.; Melninkaitis, A.; Zeidan, M.; Rayan, A. Inhibitory Effects of Ethyl Gallate on Streptococcus mutans Biofilm Formation by Optical Profilometry and Gene Expression Analysis. Molecules 2019, 24, 529. [Google Scholar] [CrossRef] [PubMed]
  9. Masalha, M.; Abu-Lafi, S.; Abu-Farich, B.; Rayan, M.; Issa, N.; Zeidan, M.; Rayan, A. A New Approach for Indexing Honey for Its Heath/Medicinal Benefits: Visualization of the Concept by Indexing Based on Antioxidant and Antibacterial Activities. Medicines 2018, 5, 135. [Google Scholar] [CrossRef] [PubMed]
  10. Masalha, M.; Rayan, M.; Adawi, A.; Abdallah, Z.; Rayan, A. Capturing antibacterial natural products with in silico techniques. Mol. Med. Rep. 2018, 18, 763–770. [Google Scholar] [CrossRef]
  11. Rayan, M.; Abdallah, Z.; Abu-Lafi, S.; Masalha, M.; Rayan, A. Indexing natural products for their antifungal activity by filters-based approach: Disclosure of discriminative properties. Curr. Comput. Aided Drug Des. 2018, 15, 235–242. [Google Scholar] [CrossRef] [PubMed]
  12. Abu-Lafi, S.; Makhamra, S.; Rayan, I.; Barriah, W.; Nasser, A.; Abu Farkh, B.; Rayan, A. Sesamin from Cuscuta palaestina natural plant extracts: Directions for new prospective applications. PLoS ONE 2018, 13, e0195707. [Google Scholar] [CrossRef] [PubMed]
  13. Said, O.; Khalil, K.; Fulder, S.; Azaizeh, H. Ethnopharmacological survey of medicinal herbs in Israel, the Golan Heights and the West Bank region. J. Ethnopharmacol. 2002, 83, 251–265. [Google Scholar] [CrossRef]
  14. Sawalha, A.F.; Sweileh, W.M.; Zyoud, S.H.; Jabi, S.W. Self-therapy practices among university students in Palestine: Focus on herbal remedies. Complement. Ther. Med. 2008, 16, 343–349. [Google Scholar] [CrossRef] [PubMed]
  15. Azaizeh, H.; Saad, B.; Khalil, K.; Said, O. The state of the art of traditional arab herbal medicine in the eastern region of the mediterranean: A review. Evid. Based Complement. Alternat. Med. 2006, 3, 229–235. [Google Scholar] [CrossRef]
  16. Adnan, S.N.; Ibrahim, N.; Yaacob, W.A. Transcriptome analysis of methicillin-resistant Staphylococcus aureus in response to stigmasterol and lupeol. J. Glob. Antimicrob. Resist. 2017, 8, 48–54. [Google Scholar] [CrossRef] [PubMed]
  17. Asadi-Samani, M.; Rafieian-Kopaei, M.; Azimi, N. Gundelia: A systematic review of medicinal and molecular perspective. Pak. J. Biol. Sci. 2013, 16, 1238–1247. [Google Scholar]
  18. Raicht, R.F.; Cohen, B.I.; Fazzini, E.P.; Sarwal, A.N.; Takahashi, M. Protective effect of plant sterols against chemically induced colon tumors in rats. Cancer Res. 1980, 40, 403–405. [Google Scholar]
  19. Yasukawa, K.; Takido, M.; Matsumoto, T.; Takeuchi, M.; Nakagawa, S. Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stage carcinogenesis. Oncology 1991, 48, 72–76. [Google Scholar] [CrossRef]
  20. Ododo, M.M.; Choudhury, M.K.; Dekebo, A.H. Structure elucidation of beta-sitosterol with antibacterial activity from the root bark of Malva parviflora. SpringerPlus 2016, 5, 1210. [Google Scholar] [CrossRef]
  21. Ali, H.; Dixit, S.; Ali, D.; Alqahtani, S.M.; Alkahtani, S.; Alarifi, S. Isolation and evaluation of anticancer efficacy of stigmasterol in a mouse model of DMBA-induced skin carcinoma. Drug Des. Dev. Ther. 2015, 9, 2793–2800. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Gomez, M.A.; Saenz, M.T.; Garcia, M.D.; Fernandez, M.A. Study of the topical anti-inflammatory activity of Achillea ageratum on chronic and acute inflammation models. Z. Naturforsch. C 1999, 54, 937–941. [Google Scholar] [CrossRef] [PubMed]
  23. Saleem, M.; Murtaza, I.; Tarapore, R.S.; Suh, Y.; Adhami, V.M.; Johnson, J.J.; Siddiqui, I.A.; Khan, N.; Asim, M.; Hafeez, B.B.; et al. Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis 2009, 30, 808–817. [Google Scholar] [CrossRef]
  24. Lopez-Lazaro, M.; Palma De La Pena, N.; Pastor, N.; Martín-Cordero, C.; Navarro, E.; Cortés, F.; Ayuso, M.J.; Toro, M.V. Anti-tumour activity of Digitalis purpurea L. subsp. heywoodii. Planta. Med. 2003, 69, 701–704. [Google Scholar] [PubMed]
  25. Abdel-Raouf, N.; Al-Enazi, N.M.; Al-Homaidan, A.A.; Ibraheem, I.B.M.; Al-Othman, M.R.; Hatamleh, A.A. Antibacterial β-amyrin isolated from Laurencia microcladia. Arab. J. Chem. 2015, 8, 32–37. [Google Scholar] [CrossRef] [Green Version]
  26. De Castilho, A.L.; da Silva, J.P.C.; Saraceni, C.H.C.; Collantes Díaz, I.E.; Paciencia, M.L.B.; Varella, A.D.; Suffredini, I.B. In vitro activity of Amazon plant extracts against Enterococcus faecalis. Braz. J. Microbiol. 2014, 45, 769–779. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Diaz-Ruiz, G.; Hernandez-Vazquez, L.; Luna, H.; Wacher-Rodarte, M.D.C.; Navarro-Ocana, A. Growth inhibition of Streptococcus from the oral cavity by alpha-amyrin esters. Molecules 2012, 17, 12603–12611. [Google Scholar] [CrossRef]
  28. Bisignano, G.; Lagana, M.G.; Trombetta, D.; Arena, S.; Nostro, A.; Uccella, N.; Mazzanti, G.; Saija, A. In vitro antibacterial activity of some aliphatic aldehydes from Olea europaea L. FEMS Microbiol. Lett. 2001, 198, 9–13. [Google Scholar] [CrossRef]
  29. Trombetta, D.; Saija, A.; Bisignano, G.; Arena, S.; Caruso, S.; Uccella, G.; Uccella, N.; Castelli, F. Study on the mechanisms of the antibacterial action of some plant alpha, beta-unsaturated aldehydes. Lett. Appl. Microbiol. 2002, 35, 285–290. [Google Scholar] [CrossRef]
  30. Wal, A.; Srivastava, R.S.; Wal, P.; Rai, A.; Sharma, S. Lupeol as a magical drug. Pharm. Biol. Eval. 2015, 2, 142–151. [Google Scholar]
Figure 1. Typical GC-MS total ion chromatograms (TICs) of wild Scolymus maculatus extracts from n-hexane (a), ethyl acetate (b), and methanol (c).
Figure 1. Typical GC-MS total ion chromatograms (TICs) of wild Scolymus maculatus extracts from n-hexane (a), ethyl acetate (b), and methanol (c).
Medicines 06 00053 g001
Figure 2. Phytochemicals stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and beta-amyrin present in wild Scolymus maculatus extracts of methanol, ethyl acetate, and n-hexane, identified by GC-MS.
Figure 2. Phytochemicals stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and beta-amyrin present in wild Scolymus maculatus extracts of methanol, ethyl acetate, and n-hexane, identified by GC-MS.
Medicines 06 00053 g002
Figure 3. Free radical scavenging of all S. maculatus five extracts. At each concentration, the experiment was run four times. The data shown are the means ± the standard error of the means from the four experiments.
Figure 3. Free radical scavenging of all S. maculatus five extracts. At each concentration, the experiment was run four times. The data shown are the means ± the standard error of the means from the four experiments.
Medicines 06 00053 g003
Table 1. Phytochemical percentages and retention times for wild S. maculatus extracts of methanol, ethyl acetate, and n-hexane, identified by gas chromatography-mass spectrometry (GC-MS).
Table 1. Phytochemical percentages and retention times for wild S. maculatus extracts of methanol, ethyl acetate, and n-hexane, identified by gas chromatography-mass spectrometry (GC-MS).
Phytochemical Names and Retention TimesArea %
No.Compound NameRT (min)MethanolEthyl Acetaten-Hexane
11-Ethylbutyl hydroperoxide9.054 6.42
21-Ethyl-2-heptylcyclopropane16.29 0.32
3Acetoglyceride18.09 1.19
42,4-Decadienal20.303 1.78
5Nonylcyclopropane21.89 0.63
6(E)-3-Octadecene26.88 0.59
7Coniferyl alcohol30.640.37
86,10,14-Trimethyl-2-pentadecanone32.360.240.40
9Ethyl palmitate35.36 0.99
10Methyl linoleate37.270.97
1114-Octadecenoic acid, methyl ester37.380.300.24
12Ethyl linolelaidate38.455 12.48
13Ethyl (9E)-9-octadecenoate38.554 2.35
14Palmitamide39.00 42.6711.97
15Doconexent40.080.69 2.61
16Oleamide42.04 5.082.90
17Octyl cyclohexanecarboxylate42.44 1.270.74
18Tetracosane44.42.150.28
19Diploptene45.16 15.68
202-Linoleoylglycerol47.085.871.460.39
21Spinacene48.49 0.470.32
22Tetratriacontane49.682.34 1.01
23Unknown54.232.04
24Stigmasterol57.642.55 0.27
25γ-Sitosterol59.585.730.221.59
26β-Amyrin61.1915.980.615.44
27Stigmasterol acetate61.33 1.27
28Lupeol63.0422.25 10.05
29Stigmastan-3,5-diene63.76 4.21
30(3α)-12-Oleanen-3-yl acetate64.239.1412.114.22
31Lupenyl acetate66.4718.1126.8211.03
32Unknown67.3311.260.167.78
Table 2. The half-maximal effective concentration (EC50) values of the radical scavenging activity of five S. maculatus extracts: aqueous, methanolic, ethanolic, ethyl acetate, and n-hexane (n = 4).
Table 2. The half-maximal effective concentration (EC50) values of the radical scavenging activity of five S. maculatus extracts: aqueous, methanolic, ethanolic, ethyl acetate, and n-hexane (n = 4).
S. maculatus Extract TypeEC50 (mg/mL)
Aqueous extract1.27
Methanolic extract0.65
Ethanolic extract0.37
Ethyl acetate extract1.08
n-hexane extract>2.0
Table 3. The minimum inhibitory concentrations (MICs) of five S. maculatus extracts (aqueous, methanolic, ethanolic, ethyl acetate, and n-hexane) against Staphylococcus aureus, Salmonella typhimurium, and Candida albicans microorganisms.
Table 3. The minimum inhibitory concentrations (MICs) of five S. maculatus extracts (aqueous, methanolic, ethanolic, ethyl acetate, and n-hexane) against Staphylococcus aureus, Salmonella typhimurium, and Candida albicans microorganisms.
Type of Extract/Microbial StrainStaphylococcus aureusSalmonella typhimuriumCandida albicans
Aqueous extract0.5 mg/mL>4.0 mg/mL1.0 mg/mL
Methanolic extract0.5 mg/mL>4.0 mg/mL0.5 mg/mL
Ethanolic extract0.5 mg/mL0.5 mg/mL0.5 mg/mL
Ethyl acetate extract0.5 mg/mL0.5 mg/mL0.5 mg/mL
n-hexane extract1.0 mg/mL>4.0 mg/mL0.5 mg/mL
Tetracycline-0.01 mg/mL-
Erythromycin0.0078 mg/mL--
Nystatin--0.00312 mg/mL

Share and Cite

MDPI and ACS Style

Abu-Lafi, S.; Rayan, M.; Masalha, M.; Abu-Farich, B.; Al-Jaas, H.; Abu-Lafi, M.; Rayan, A. Phytochemical Composition and Biological Activities of Wild Scolymus maculatus L. Medicines 2019, 6, 53. https://doi.org/10.3390/medicines6020053

AMA Style

Abu-Lafi S, Rayan M, Masalha M, Abu-Farich B, Al-Jaas H, Abu-Lafi M, Rayan A. Phytochemical Composition and Biological Activities of Wild Scolymus maculatus L. Medicines. 2019; 6(2):53. https://doi.org/10.3390/medicines6020053

Chicago/Turabian Style

Abu-Lafi, Saleh, Mahmoud Rayan, Mahmud Masalha, Basheer Abu-Farich, Hashem Al-Jaas, Malek Abu-Lafi, and Anwar Rayan. 2019. "Phytochemical Composition and Biological Activities of Wild Scolymus maculatus L." Medicines 6, no. 2: 53. https://doi.org/10.3390/medicines6020053

APA Style

Abu-Lafi, S., Rayan, M., Masalha, M., Abu-Farich, B., Al-Jaas, H., Abu-Lafi, M., & Rayan, A. (2019). Phytochemical Composition and Biological Activities of Wild Scolymus maculatus L. Medicines, 6(2), 53. https://doi.org/10.3390/medicines6020053

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop